The Past, Present, and Future of GRASP: Connecting Cancer Researchers, Clinicians, and Patient Advocates
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
Experts outline treatment options for patients with venetoclax resistance.
Immune checkpoint inhibitor therapies have improved survival in patients with non-small cell lung cancer, but they have also been linked to immune-related adverse events affecting various organs, including the lungs.
Patients with malignant pleural effusion may care more about relieving symptoms such as dyspnea as opposed to achieving pleurodesis.
Research is still needed to explore the association between cancer chemotherapeutics and rheumatoid arthritis.
Any images and personal stories that remind people about skin cancer, what to look for, even scars after surgery, really help save lives.
As failure to recognize depression symptoms contributes to the association between mortality and depression in cancer patients, early recognition and treatment with pharmacologic and/or psychologic support is essential for improving outcomes.